Performance evaluation of abbott realtime HBV quantification kit for HBV viral load by real-time PCR

Korean Journal of Laboratory Medicine

Volumn 28, Issue 2, 2008, Pages 144-150

  Kim, Myeong Hee ^a   Cha, Choong Hwan ^a   An, Dongheui ^a   Choi, Sung Eun ^a   Oh, Heung Bum ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Evaluation; Hepatitis B virus; Performance; Real time PCR

Indexed keywords

VIRUS DNA;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; COMPUTER SYSTEM; EVALUATION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS LOAD;

COMPUTER SYSTEMS; DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; VIRAL LOAD;

EID: 51449122725     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.2.144     Document Type: Article

References (24)

1. Di Bisceglie A, Lai CL, Gane E, Chen YC, Thongsawat S, Wang Y, et al. Telbivudine globe trial: maximal early HBV suppression is predictive of optimal two-year efficacy in nucleoside-treated hepatitis B patients. Hepatology 2006;44(S1):230-1.
2. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 2006;131:1743-51. (Pubitemid 44958517)
3. Yuen MF, Sablon E, Hui CK, Yuan HJ, Decraemer H, Lai CL. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 2001;34:785-91. (Pubitemid 32928004)
4. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73. (Pubitemid 43042691)
5. Kim SH, Ki CS, Park HK, Cho HJ, Kim JW, Park SS, et al. Annual report on external quality assessment in diagnostic genetics in Korea (2006). J Lab Med Qual Assur 2007;29:153-74.
6. Konnick EQ, Erali M, Ashwood ER, Hillyard DR. Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA. J Clin Microbiol 2005;43:596-603. (Pubitemid 40256006)
7. Pawlotsky JM, Bastie A, Hezode C, Lonjon I, Darthuy F, Remire J, et al. Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods 2000;85:11-21. (Pubitemid 30068578)
8. Lee HC, Suh DJ, Ryu SH, Kim H, Shin JW, Lim YS, et al. Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion. Gut 2003; 52:1779-83. (Pubitemid 37510403)
9. Lok AS and McMahon BJ. Chronic hepatitis B. Hepatology 2007;45: 507-39. (Pubitemid 46374607)
10. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004;10:190-212. (Pubitemid 38379958)
11. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276-80. (Pubitemid 21915133)
12. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 1993;21: 3761-6. (Pubitemid 23254498)
13. Valasek MA and Repa JJ. The power of real-time PCR. Adv Physiol Educ 2005;29:151-9. (Pubitemid 41215473)
14. Hwang SH, Cha CH, Kim YL, Kwon OJ, Oh HB. Performance evaluation of Real-Q HBV Quantification Kit for HBV DNA by real-time PCR. Korean J Lab Med 2006;26:442-8.
15. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63. (Pubitemid 29489740)
16. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998;339:61-8. (Pubitemid 28304879)
17. Schalm SW, Heathcote J, Cianciara J, Farrell G, Sherman M, Willems B, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 2000;46:562-8. (Pubitemid 30305823)
18. Chang TT, Lai CL, Chien RN, Guan R, Lim SG, Lee CM, et al. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 2004;19:1276-82. (Pubitemid 39481762)
19. Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, et al. Longterm safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003;125:1714-22. (Pubitemid 37500436)
20. Fung SK, Chae HB, Fontana RJ, Conjeevaram H, Marrero J, Oberhelman K, et al. Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol 2006;44:283-90. (Pubitemid 43069209)
21. Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology 2006;43:1385-91. (Pubitemid 43980117)
22. Klein D. Quantification using real-time PCR technology: applications and limitations. Trends Mol Med 2002;8:257-60. (Pubitemid 34568376)
23. Laperche S, Thibault V, Bouchardeau F, Alain S, Castelain S, Gassin M, et al. Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol 2006;44:3600-7. (Pubitemid 46768819)
24. Weiss J, Wu H, Farrenkopf B, Schultz T, Song G, Shah S, et al. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol 2004;30:86-93. (Pubitemid 38457074)